Failure to Thrive: Clinical Trials

4 trials for Failure to Thrive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 2
Phase 11Terminated 1
Phase 31Terminated 1

Follow Failure to Thrive: new trials by email Literature Review of Failure to Thrive trials Research Report on Failure to Thrive

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas
Damira/Celia peptide hydrolyzed casein, Picot riz/Celia rice/Sanutri arroz - Cow Milk Protein Sensitivity, Tolerance
Phase 2CompletedLactalis1142013-03-012015-04-17
Prophylactic Probiotics to Extremely Low Birth Weight Prematures
Lactobacillus reuteri, Placebo - Feeding; Difficult, Newborn, Growth Failure
Phase 2CompletedOstergotland County Council, Sweden1342012-06-012024-08-13
Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
somatropin [rDNA origin] for injection - Arthritis, Juvenile Rheumatoid, Crohn Disease
Phase 2 / Phase 3TerminatedNationwide Children's Hospital102007-08-012018-04-12
Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
Increlex - Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID)
Phase 1 / Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)62007-06-012015-07-03

Narrower conditions

Arthritis, Juvenile (1)  ·  Body Weight (1)  ·  Chronic Disease (1)  ·  Crohn Disease (1)  ·  Dwarfism (1)  ·  Enterocolitis, Necrotizing (1)  ·  Hypersensitivity (1)  ·  Sepsis (1)  ·  X-Linked Combined Immunodeficiency Diseases (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Immune System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Intestinal Diseases (2)  ·  Pathologic Processes (2)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Connective Tissue Diseases (1)

Interventions

Human Growth Hormone (1)  ·  WW Domain-Containing Oxidoreductase (1)  ·  mecasermin (1)

Sponsors

Lactalis (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Nationwide Children's Hospital (1)  ·  Ostergotland County Council, Sweden (1)

Countries

United States (2)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Dana S Hardin, MD (1)  ·  Suk S De Ravin, M.D. (1)  ·  Thomas Abrahamsson, MD, PhD (1)

Results publications

PMID 33763652, PMID 33923278